SCHEMBL14348362

SCHEMBL14348362

Nc1cccc(Nc2nccc(-c3ccc(NC(=O)CN4CCSCC4)cc3)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 11/20 0.56
HDAC1 Q13547 5/20 0.56
HDAC6 Q9UBN7 5/20 0.56
ABL1 P00519 2/20 0.53
BCR P11274 2/20 0.53
SRC P12931 2/20 0.53
EGFR P00533 1/20 0.52
PRKACA P17612 1/20 0.52
PRKACG P22612 1/20 0.52
PRKACB P22694 1/20 0.52
CDK5 Q00535 1/20 0.52
IKBKB O14920 1/20 0.50
CHUK O15111 1/20 0.50
JAK3 P52333 2/20 0.47
PLK1 P53350 1/20 0.47
CAMK2D Q13557 1/20 0.46
PIK3CG P48736 2/20 0.46
CDK1 P06493 1/20 0.46
CDK2 P24941 1/20 0.46
PIK3CA P42336 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14348343 0.93 ABL1 (0.54) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL4382875 0.89 JAK2 (0.63) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL8349351 0.89 JAK2 (0.58) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL14348354 0.88 JAK2 (0.54) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL14348352 0.83 JAK2 (0.51) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL8349109 0.82 JAK2 (0.61) JAK2ABL1BCRSRCEGFR
SCHEMBL8349401 0.81 JAK2 (0.53) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL14338280 0.80 JAK2 (0.49) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL4381980 0.79 JAK2 (0.74) JAK2HDAC1HDAC6ABL1BCR
SCHEMBL3015105 0.78 CDK5 (0.60) JAK2HDAC1HDAC6ABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed